A randomized controlled trial on the effectiveness of strength training on clinical and muscle cellular outcomes in patients with prostate cancer during androgen deprivation therapy: Rationale and design

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Thorsen, Lene ^a   Nilsen, Tormod S ^b   Raastad, Truls ^b   Courneya, Kerry S ^c   Skovlund, Eva ^d,e   Fosså, Sophie D ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b Norwegian School of Sports Sciences   (Norway)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF OSLO   (Norway)

^e NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

Androgen deprivation therapy; Clinical and muscle cellular outcomes; Prostate cancer; Strength training

Indexed keywords

ANDROGEN DEPRIVATION THERAPY; ARTICLE; BONE DENSITY; CANCER RADIOTHERAPY; CELL FUNCTION; CELL STRESS; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; EXERCISE; FUNCTIONAL ASSESSMENT; HUMAN; LEAN BODY WEIGHT; MALE; MITOCHONDRION; MUSCLE CELL; MUSCLE STRENGTH; MUSCLE TRAINING; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; SEROLOGY; SOCIAL PSYCHOLOGY; TREATMENT DURATION; BODY COMPOSITION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; FATIGUE; FEASIBILITY STUDY; HISTOLOGY; KINESIOTHERAPY; METHODOLOGY; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSTATE TUMOR; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; RESISTANCE TRAINING; SKELETAL MUSCLE;

ANTIANDROGEN;

ANDROGEN ANTAGONISTS; BODY COMPOSITION; COMBINED MODALITY THERAPY; EXERCISE THERAPY; FATIGUE; FEASIBILITY STUDIES; HUMANS; MALE; MUSCLE STRENGTH; MUSCLE, SKELETAL; PROSTATIC NEOPLASMS; QUALITY OF LIFE; RESISTANCE TRAINING;

EID: 84858962803     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-123     Document Type: Article

References (57)

1. Bolla M, Collette L, Blank L, Warde P, Dubois JB, Mirimanoff RO, Storme G, Bernier J, Kuten A, Sternberg C, Mattelaer J, Lopez TJ, Pfeffer JR, Lino CC, Zurlo A, Pierart M. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 2002, 360:103-106. 10.1016/S0140-6736(02)09408-4, 12126818.
2. Boxer RS, Kenny AM, Dowsett R, Taxel P. The effect of 6 months of androgen deprivation therapy on muscle and fat mass in older men with localized prostate cancer. Aging Male 2005, 8:207-212. 10.1080/13685530500361226, 16390748.
3. Schmitz KH, Holtzman J, Courneya KS, Masse LC, Duval S, Kane R. Controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2005, 14:1588-1595. 10.1158/1055-9965.EPI-04-0703, 16030088.
4. Speck RM, Courneya KS, Masse LC, Duval S, Schmitz KH. An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. J Cancer Surviv 2010, 4:87-100. 10.1007/s11764-009-0110-5, 20052559.
5. Baumann FT, Zopf EM, Bloch W. Clinical exercise interventions in prostate cancer patients-a systematic review of randomized controlled trials. Support Care Cancer 2012, 20:221-233. 10.1007/s00520-011-1271-0, 21989678.
6. Lexell J, Taylor CC, Sjostrom M. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15- to 83-year-old men. J Neurol Sci 1988, 84:275-294. 10.1016/0022-510X(88)90132-3, 3379447.
7. Vermeulen A, Goemaere S, Kaufman JM. Testosterone, body composition and aging. J Endocrinol Invest 1999, 22:110-116.
8. Morley JE. Testosterone and behavior. Clin Geriatr Med 2003, 19:605-616. 10.1016/S0749-0690(02)00106-4, 14567011.
9. Haseen F, Murray LJ, Cardwell CR, O'Sullivan JM, Cantwell MM. The effect of androgen deprivation therapy on body composition in men with prostate cancer: systematic review and meta-analysis. J Cancer Surviv 2010, 4:128-139. 10.1007/s11764-009-0114-1, 20091248.
10. Preston DM, Torrens JI, Harding P, Howard RS, Duncan WE, McLeod DG. Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss. Prostate Cancer Prostatic Dis 2002, 5:304-310. 10.1038/sj.pcan.4500599, 12627216.
11. Greenspan SL, Coates P, Sereika SM, Nelson JB, Trump DL, Resnick NM. Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer. J Clin Endocrinol Metab 2005, 90:6410-6417. 10.1210/jc.2005-0183, 16189261.
12. Pirl WF, Siegel GI, Goode MJ, Smith MR. Depression in men receiving androgen deprivation therapy for prostate cancer: a pilot study. Psychooncology 2002, 11:518-523. 10.1002/pon.592, 12476433.
13. Stone P, Hardy J, Huddart R, A'Hern R, Richards M. Fatigue in patients with prostate cancer receiving hormone therapy. Eur J Cancer 2000, 36:1134-1141. 10.1016/S0959-8049(00)00084-8, 10854947.
14. Kadi F, Charifi N, Denis C, Lexell J, Andersen JL, Schjerling P, Olsen S, Kjaer M. The behaviour of satellite cells in response to exercise: what have we learned from human studies?. Pflugers Arch 2005, 451:319-327. 10.1007/s00424-005-1406-6, 16091958.
15. Jennische E, Skottner A, Hansson HA. Satellite cells express the trophic factor IGF-I in regenerating skeletal muscle. Acta Physiol Scand 1987, 129:9-15. 10.1111/j.1748-1716.1987.tb08034.x, 3551503.
16. Sinha-Hikim I, Taylor WE, Gonzalez-Cadavid NF, Zheng W, Bhasin S. Androgen receptor in human skeletal muscle and cultured muscle satellite cells: up-regulation by androgen treatment. J Clin Endocrinol Metab 2004, 89:5245-5255. 10.1210/jc.2004-0084, 15472231.
17. Sinha-Hikim I, Artaza J, Woodhouse L, Gonzalez-Cadavid N, Singh AB, Lee MI, Storer TW, Casaburi R, Shen R, Bhasin S. Testosterone-induced increase in muscle size in healthy young men is associated with muscle fiber hypertrophy. Am J Physiol Endocrinol Metab 2002, 283:E154-E164.
18. Sinha-Hikim I, Roth SM, Lee MI, Bhasin S. Testosterone-induced muscle hypertrophy is associated with an increase in satellite cell number in healthy, young men. Am J Physiol Endocrinol Metab 2003, 285:E197-E205.
19. Smith MR. Changes in fat and lean body mass during androgen-deprivation therapy for prostate cancer. Urology 2004, 63:742-745. 10.1016/j.urology.2003.10.063, 15072892.
20. Berruti A, Dogliotti L, Terrone C, Cerutti S, Isaia G, Tarabuzzi R, Reimondo G, Mari M, Ardissone P, De LS, Fasolis G, Fontana D, Rossetti SR, Angeli A. Changes in bone mineral density, lean body mass and fat content as measured by dual energy x-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy. J Urol 2002, 167:2361-2367. 10.1016/S0022-5347(05)64985-3, 11992038.
21. Zhao W, Pan J, Wang X, Wu Y, Bauman WA, Cardozo CP. Expression of the muscle atrophy factor muscle atrophy F-box is suppressed by testosterone. Endocrinology 2008, 149:5449-5460. 10.1210/en.2008-0664, 18599544.
22. Hoppeler H, Fluck M. Plasticity of skeletal muscle mitochondria: structure and function. Med Sci Sports Exerc 2003, 35:95-104. 10.1097/00005768-200301000-00016, 12544642.
23. Morton JP, Kayani AC, McArdle A, Drust B. The exercise-induced stress response of skeletal muscle, with specific emphasis on humans. Sports Med 2009, 39:643-662. 10.2165/00007256-200939080-00003, 19769414.
24. Oner J, Oner H, Sahin Z, Demir R, Ustunel I. Melatonin is as effective as testosterone in the prevention of soleus muscle atrophy induced by castration in rats. Anat Rec (Hoboken) 2008, 291:448-455.
25. Milne KJ, Thorp DB, Melling CW, Noble EG. Castration inhibits exercise-induced accumulation of Hsp70 in male rodent hearts. Am J Physiol Heart Circ Physiol 2006, 290:H1610-H1616.
26. Fiatarone MA, O'Neill EF, Ryan ND, Clements KM, Solares GR, Nelson ME, Roberts SB, Kehayias JJ, Lipsitz LA, Evans WJ. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med 1994, 330:1769-1775. 10.1056/NEJM199406233302501, 8190152.
27. Nelson ME, Fiatarone MA, Morganti CM, Trice I, Greenberg RA, Evans WJ. Effects of high-intensity strength training on multiple risk factors for osteoporotic fractures. A randomized controlled trial. JAMA 1994, 272:1909-1914. 10.1001/jama.1994.03520240037038, 7990242.
28. Vincent KR, Braith RW. Resistance exercise and bone turnover in elderly men and women. Med Sci Sports Exerc 2002, 34:17-23.
29. Abe T, Kojima K, Kearns CF, Yohena H, Fukuda J. Whole body muscle hypertrophy from resistance training: distribution and total mass. Br J Sports Med 2003, 37:543-545. 10.1136/bjsm.37.6.543, 1724694, 14665598.
30. Hunter GR, McCarthy JP, Bamman MM. Effects of resistance training on older adults. Sports Med 2004, 34:329-348. 10.2165/00007256-200434050-00005, 15107011.
31. Menkes A, Mazel S, Redmond RA, Koffler K, Libanati CR, Gundberg CM, Zizic TM, Hagberg JM, Pratley RE, Hurley BF. Strength training increases regional bone mineral density and bone remodeling in middle-aged and older men. J Appl Physiol 1993, 74:2478-2484.
32. Ryan AS, Treuth MS, Rubin MA, Miller JP, Nicklas BJ, Landis DM, Pratley RE, Libanati CR, Gundberg CM, Hurley BF. Effects of strength training on bone mineral density: hormonal and bone turnover relationships. J Appl Physiol 1994, 77:1678-1684.
33. Vincent KR, Braith RW. Resistance exercise and bone turnover in elderly men and women. Med Sci Sports Exerc 2002, 34:17-23.
34. Thorsen L, Courneya KS, Stevinson C, Fossa SD. A systematic review of physical activity in prostate cancer survivors: outcomes, prevalence, and determinants. Support Care Cancer 2008, 16:987-997. 10.1007/s00520-008-0411-7, 18274783.
35. Keogh JW, Macleod RD. Body composition, physical fitness, functional performance, quality of life, and fatigue benefits of exercise for prostate cancer patients: a systematic review. J Pain Symptom Manage 2012, 43:96-110. 10.1016/j.jpainsymman.2011.03.006, 21640547.
36. Kadi F. Adaptation of human skeletal muscle to training and anabolic steroids. Acta Physiol Scand Suppl 2000, 646:1-52.
37. Roth SM, Martel GF, Ivey FM, Lemmer JT, Tracy BL, Metter EJ, Hurley BF, Rogers MA. Skeletal muscle satellite cell characteristics in young and older men and women after heavy resistance strength training. J Gerontol A Biol Sci Med Sci 2001, 56:B240-B247. 10.1093/gerona/56.6.B240, 11382785.
38. Tatsumi R. Mechano-biology of skeletal muscle hypertrophy and regeneration: possible mechanism of stretch-induced activation of resident myogenic stem cells. Anim Sci J 2010, 81:11-20. 10.1111/j.1740-0929.2009.00712.x, 20163667.
39. Kvorning T, Andersen M, Brixen K, Schjerling P, Suetta C, Madsen K. Suppression of testosterone does not blunt mRNA expression of myoD, myogenin, IGF, myostatin or androgen receptor post strength training in humans. J Physiol 2007, 578:579-593. 2075150, 17095559.
40. Kvorning T, Andersen M, Brixen K, Madsen K. Suppression of endogenous testosterone production attenuates the response to strength training: a randomized, placebo-controlled, and blinded intervention study. Am J Physiol Endocrinol Metab 2006, 291:E1325-E1332. 10.1152/ajpendo.00143.2006, 16868226.
41. Tang JE, Hartman JW, Phillips SM. Increased muscle oxidative potential following resistance training induced fibre hypertrophy in young men. Appl Physiol Nutr Metab 2006, 31:495-501. 10.1139/h06-026, 17111003.
42. Paulsen G, Hanssen KE, Ronnestad BR, Kvamme NH, Ugelstad I, Kadi F, Raastad T. Strength training elevates HSP27, HSP70 and alphaB-crystallin levels in musculi vastus lateralis and trapezius. Eur J Appl Physiol 2011,
43. Lilleby W, Tafjord G, Raabe NK. Implementation of High-dose-rate Brachytherapy and Androgen Deprivation in Patients with Prostate Cancer. Int J Radiat Oncol Biol Phys 2011,
44. Segal RJ, Reid RD, Courneya KS, Malone SC, Parliament MB, Scott CG, Venner PM, Quinney HA, Jones LW, D'Angelo ME, Wells GA. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 2003, 21:1653-1659. 10.1200/JCO.2003.09.534, 12721238.
45. Kadi F, Bonnerud P, Eriksson A, Thornell LE. The expression of androgen receptors in human neck and limb muscles: effects of training and self-administration of androgenic-anabolic steroids. Histochem Cell Biol 2000, 113:25-29. 10.1007/s004180050003, 10664066.
46. Simmonds MJ. Physical function in patients with cancer: psychometric characteristics and clinical usefulness of a physical performance test battery. J Pain Symptom Manage 2002, 24:404-414. 10.1016/S0885-3924(02)00502-X, 12505209.
47. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983, 67:361-370. 10.1111/j.1600-0447.1983.tb09716.x, 6880820.
48. Chalder T, Berelowitz G, Pawlikowska T, Watts L, Wessely S, Wright D, Wallace EP. Development of a fatigue scale. J Psychosom Res 1993, 37:147-153. 10.1016/0022-3999(93)90081-P, 8463991.
49. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993, 85:365-376. 10.1093/jnci/85.5.365, 8433390.
50. Godin G, Shephard RJ. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci 1985, 10:141-146.
51. Svilaas A, Strom EC, Svilaas T, Borgejordet A, Thoresen M, Ose L. Reproducibility and validity of a short food questionnaire for the assessment of dietary habits. Nutr Metab Cardiovasc Dis 2002, 12:60-70.
52. Jones LW, Douglas PS, Eves ND, Marcom PK, Kraus WE, Herndon JE, Inman BA, Allen JD, Peppercorn J. Rationale and design of the Exercise Intensity Trial (EXCITE): A randomized trial comparing the effects of moderate versus moderate to high-intensity aerobic training in women with operable breast cancer. BMC Cancer 2010, 10:531. 10.1186/1471-2407-10-531, 2965727, 20925920.
53. Jones LW, Eves ND, Kraus WE, Potti A, Crawford J, Blumenthal JA, Peterson BL, Douglas PS. The lung cancer exercise training study: a randomized trial of aerobic training, resistance training, or both in postsurgical lung cancer patients: rationale and design. BMC Cancer 2010, 10:155. 10.1186/1471-2407-10-155, 2888787, 20409311.
54. Christensen JF, Andersen JL, Adamsen L, Lindegaard B, Mackey AL, Nielsen RH, Rorth M, Daugaard G. Progressive resistance training and cancer testis (PROTRACT) - efficacy of resistance training on muscle function, morphology and inflammatory profile in testicular cancer patients undergoing chemotherapy: design of a randomized controlled trial. BMC Cancer 2011, 11:326. 10.1186/1471-2407-11-326, 3176239, 21806789.
55. Segal RJ, Reid RD, Courneya KS, Sigal RJ, Kenny GP, Prud'Homme DG, Malone SC, Wells GA, Scott CG, Slovinec D'Angelo ME. Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J Clin Oncol 2009, 27:344-351.
56. Galvao DA, Nosaka K, Taaffe DR, Spry N, Kristjanson LJ, McGuigan MR, Suzuki K, Yamaya K, Newton RU. Resistance training and reduction of treatment side effects in prostate cancer patients. Med Sci Sports Exerc 2006, 38:2045-2052. 10.1249/01.mss.0000233803.48691.8b, 17146309.
57. Wernbom M, Augustsson J, Thomee R. The influence of frequency, intensity, volume and mode of strength training on whole muscle cross-sectional area in humans. Sports Med 2007, 37:225-264. 10.2165/00007256-200737030-00004, 17326698.